相关实验视频

Updated: Sep 17, 2025

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Published on: May 25, 2018

精确纠正Pde6b-L659P突变导致视网膜退化,通过先进的基因组编辑工具进行最小旁观者编辑

Zhiquan Liu¹, Siyu Chen¹, Yang Sun^1,2

¹Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, CA 94304, USA.

Research (Washington, D.C.)

|July 3, 2025

概括

主编辑 (PE) 为导致视网膜退化的Pde6b突变提供了最精确的基因组编辑,为未来的基因疗法应用显示了希望.

科学领域:

遗传学是一个遗传学.
分子生物学分子生物学
眼科医生眼科眼科

背景情况:

新型基因组编辑技术,如基因编辑 (BE),主要编辑 (PE) 和点击编辑 (CE),提供精确的基因修改,降低风险.
缺乏对这些先进的编辑工具进行系统的比较,以纠正引起疾病的突变.

研究的目的:

评估和比较BE,PE和CE在纠正导致视网膜退化的Pde6b (c.1976T>C,p.L659P) 突变方面的疗效和精度.
评估这些技术在遗传性视网膜疾病的小鼠模型中治疗应用的潜力.

主要方法:

使用Pde6b-L659P细胞模型进行BE,PE和CE系统的体外优化.
深度测序分析以比较三种技术中的编辑效率,精度和旁观者效果.
在Pde6b-L659P小鼠中对优化的原始编辑系统进行体内电解.

主要成果:

主编辑表现出最高的精度,与基础编辑和点击编辑相比,显著减少旁观者编辑.
点击编辑表现出更低的效率和更高的indel率,表明需要进一步优化.
在小鼠体内应用原始编辑实现了12.4%的目标修复,导致视网膜退化部分恢复.

结论:

主编辑是一种非常精确的基因组编辑工具,适用于纠正导致视网膜退化的Pde6b突变.
这项研究提供了使用BE,PE和CE技术来解决视网膜疾病背后的遗传突变的概念证明.
这些发现突显了精确基因编辑在遗传性视网膜疾病中的未来治疗策略的潜力.

更多相关视频

Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development

Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development

Published on: March 5, 2017

CRISPR/Cas9 Ribonucleoprotein-mediated Precise Gene Editing by Tube Electroporation

CRISPR/Cas9 Ribonucleoprotein-mediated Precise Gene Editing by Tube Electroporation

Published on: June 20, 2019

相关概念视频

CRISPR/Cas9 Genome Editing

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.